Osimertinib as first-line therapy in advanced NSCLC: a profile of its use Lesley J. Scott Adis Drug Q&A Open access 06 July 2018 Pages: 351 - 357
Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use Kate McKeageKatherine A. Lyseng-Williamson Adis Drug Q&A Open access 11 July 2018 Pages: 358 - 366
First reports of adverse drug reactions Drug Reactions and Interactions 12 July 2018 Pages: 367 - 367
Consider potential drug interactions when starting combination therapy with antiepileptic drugs Adis Medical Writers Drug Reactions and Interactions 29 May 2018 Pages: 368 - 371
Antipsychotic drugs may increase the risk of venous thromboembolism Adis Medical Writers Drug Reactions and Interactions 28 June 2018 Pages: 372 - 376
Reducing clinical risks associated with the pharmacological treatment of acute gout attacks Sanja Mirkov Therapy in Practice 17 May 2018 Pages: 377 - 385
Prediction of cardiovascular risk in a rural Indian population using WHO/ISH risk prediction charts: a community-based cross-sectional study B. R. Venkhat BalajiM. G. RajanandhP. Seenivasan Original Research Article 10 May 2018 Pages: 386 - 391
Defining an ‘older’ patient in the context of therapeutic decision making: perspectives of Australian pharmacists and nurses Natalia KrzyżaniakShamsher SinghBeata Bajorek Original Research Article 14 May 2018 Pages: 392 - 401
Candida endocarditis and the impact of antifungal treatment on the corrected QT interval: a case report Elda RighiDaniele MuserMatteo Bassetti Short Communication 18 May 2018 Pages: 402 - 403
Correction to: Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use Katherine A. Lyseng-Williamson Correction Open access 26 June 2018 Pages: 404 - 404
